Delivery Order SPE2DR25D3012-SPE2DR26F4E3Q
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Methylphenidate ER 18 mg tablets in a quantity of 100 units, with a ceiling value of $1,176.87 and a firm fixed price structure. The order is scheduled for completion by November 28, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and is issued under the...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for methylphenidate ER 36 mg tablets (100 count) on November 7, 2025, with a ceiling value of $2,593.37 and completion deadline of November 10, 2025. This competitively awarded contract utilizing firm fixed pricing represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Methylphenidate ER 18 mg tablets (100-count bottles) valued at $2,634.43. This is a firm fixed price delivery order with an ultimate completion date of August 15, 2025, and represents a non-competitive set-aside award. The order will be fulfilled from AmerisourceBergen's facility located in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 18 mg tablets (100-count containers) under a firm fixed-price contract with a ceiling value of $1,252.88. The award, issued on December 31, 2025, with an ultimate completion date of January 2, 2026, represents a competitively awarded, non-set-aside procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of methylphenidate ER 18mg tablets (100 count) under a firm fixed-price contract valued at $4,919.16. This non-set-aside award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement running through December 2026. The contract is set to be completed...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Methylphenidate ER 36 mg tablets in a quantity of 100 units, with a contract ceiling value of $1,647.48. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and is scheduled for completion by September 25,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Methylphenidate ER 18 mg tablets (100-count) with a ceiling value of $1,459.68 under firm fixed price terms. The award was made on January 5, 2026, with an ultimate completion date of January 6, 2026. This competitively awarded, non-set-aside contract represents a routine pharmaceutical supply transaction for the federal medical procurement system. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for methylphenidate ER 27 mg tablets (100-count supply) with a ceiling value of $1,146.20. This firm fixed-price, competitively awarded contract was issued on December 30, 2025, with an ultimate completion date of December 31, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract utilizes no set-aside designation, reflecting open competition...
- The Defense Logistics Agency awarded a delivery order valued at $3,612.72 to AmerisourceBergen Drug Corp for Methylphenidate ER 18 mg tablets (100-count supply) on July 14, 2025, with completion targeted for July 15, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded contract under the company's larger indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Methylphenidate ER 18 mg tablets in a quantity of 100s, with a ceiling value of $3,038.08 under a firm fixed-price arrangement. This delivery order represents a non-set-aside competitive award with an ultimate completion date of December 9, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major...
- SPE2DR25D3012Indefinite Delivery Contract
- SPE2DR25D3012-SPE2DR26F4E3QDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Methylphenidate ER 18 mg tablets (100-count bottles) with a ceiling value of $6,686.71 under firm fixed pricing. This is a non-set-aside contract, indicating it was competitively awarded. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The delivery order is scheduled for completion by January 6, 2026, with performance taking place at the company's Conshohocken facility. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling supply of a broad range of medications and medical supplies to Defense Health Agency customers and other federal healthcare systems worldwide. Methylphenidate, a controlled stimulant medication commonly used in ADHD treatment, represents one element of the extensive pharmaceutical portfolio AmerisourceBergen delivers through this strategic contract vehicle supporting military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.7k | 1/4/26 |